Reply: 'Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.

Omlin, A; Pezaro, C J; Zaidi, S; Lorente, D; Mukherji, D; Bianchini, D; Ferraldeschi, R; Sandhu, S; Dearnaley, D; Parker, C; Van As, N; de Bono, J S; Attard, G

Omlin, A; Pezaro, C J; Zaidi, S; Lorente, D; Mukherji, D; Bianchini, D; Ferraldeschi, R; Sandhu, S; Dearnaley, D; Parker, C; Van As, N; de Bono, J S; Attard, G.

Afiliación

Omlin A; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.
Pezaro CJ; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.
Zaidi S; Academic Urology Unit, Sutton, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
Lorente D; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.
Mukherji D; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.
Bianchini D; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.
Ferraldeschi R; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.
Sandhu S; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.
Dearnaley D; Academic Urology Unit, Sutton, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK.
Parker C; Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK.
Van As N; Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK.
de Bono JS; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.
Attard G; Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK.

Br J Cancer ; 110(1): 267-8, 2014 Jan 07.

Article en En | MEDLINE | ID: mdl-24300975

Asunto(s)

Androstenoles/uso terapéutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Dietilestilbestrol/uso terapéutico; Estrógenos no Esteroides/uso terapéutico; Neoplasias de la Próstata/tratamiento farmacológico; Esteroide 17-alfa-Hidroxilasa/antagonistas & inhibidores; Humanos; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Esteroide 17-alfa-Hidroxilasa / Protocolos de Quimioterapia Combinada Antineoplásica / Dietilestilbestrol / Estrógenos no Esteroides / Androstenoles Límite: Humans / Male Idioma: En Revista: Br J Cancer Año: 2014 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google